Literature DB >> 21992713

Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates.

María A del Buey1, José A Cristóbal, Paula Casas, Pilar Goñi, Antonio Clavel, Enrique Mínguez, Elena Lanchares, Alicia García, Begoña Calvo.   

Abstract

PURPOSE: To evaluate in vitro the amoebicidal effects of riboflavin and ultraviolet A (UVA) collagen cross-linking.
DESIGN: Experimental study, laboratory investigation.
METHODS: Two different strains of Acanthamoeba species were tested identically. Four treatment groups were considered: group 1 consisted of 0.1% riboflavin and 30-minute UVA irradiation; group 2 consisted of 0.1% riboflavin and 60-minute UVA irradiation; group 3 consisted of no riboflavin and no UVA exposure; group 4 consisted of 0.1% riboflavin and no UVA exposure. The application of UVA was performed under the parameters used for in vivo corneal collagen cross-linking.
RESULTS: In all cases, cysts and trophozoites were detected 24 hours after treatment at a radial distance from the center of the seeding point more than 5 mm, indicating that the amoebae were viable. All treated and untreated groups of amoebae from the 2 strains exhibited growth (radii of 14 to 15 mm in groups 1, 3, and 4; radius of 12 mm in group 2). The final morphologic features of the 2 strains of trophozoites that received treatment were similar to those of the initial seeding group and the untreated control group.
CONCLUSIONS: The results obtained in our study show that a single dose (30 or 60 minutes) of cross-linking cannot achieve eradication in the 2 different Acanthamoeba strains examined. However, in vitro results do not always indicate in vivo efficacy, so future studies should test the validity of this treatment for Acanthamoeba keratitis. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21992713     DOI: 10.1016/j.ajo.2011.07.025

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  22 in total

1.  Crosslinking and corneal cryotherapy in acanthamoeba keratitis -- a histological study.

Authors:  Tobias Hager; A Hasenfus; T Stachon; B Seitz; N Szentmáry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01       Impact factor: 3.117

Review 2.  Therapeutic and inducing effect of corneal crosslinking on infectious keratitis.

Authors:  Liang-Zhu Jiang; Shi-Yan Qiu; Zhi-Wei Li; Xiao Zhang; Xiang-Chen Tao; Guo-Ying Mu
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

3.  Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts.

Authors:  Ricardo Lamy; Elliot Chan; Samuel D Good; Vicky Cevallos; Travis C Porco; Jay M Stewart
Journal:  Clin Exp Ophthalmol       Date:  2016-02-23       Impact factor: 4.207

4.  Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates.

Authors:  Alejandro Arboleda; Darlene Miller; Florence Cabot; Mukesh Taneja; Mariela C Aguilar; Karam Alawa; Guillermo Amescua; Sonia H Yoo; Jean-Marie Parel
Journal:  Am J Ophthalmol       Date:  2014-04-29       Impact factor: 5.258

5.  Comparison of UVA- and UVA/riboflavin-induced growth inhibition of Acanthamoeba castellanii.

Authors:  Karim Makdoumi; Anders Bäckman; Jes Mortensen; Anders Magnuson; Sven Crafoord
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-19       Impact factor: 3.117

6.  Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration.

Authors:  Renata T Kashiwabuchi; Fabio R S Carvalho; Yasin A Khan; Flavio Hirai; Mauro S Campos; Peter J McDonnell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-25       Impact factor: 3.117

7.  Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.

Authors:  Brian Shing; Mina Balen; James H McKerrow; Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-05-19       Impact factor: 5.091

8.  PACK-CXL: Corneal Cross-linking for Treatment of Infectious Keratitis.

Authors:  David Tabibian; Olivier Richoz; Farhad Hafezi
Journal:  J Ophthalmic Vis Res       Date:  2015 Jan-Mar

9.  Advances in the diagnosis and treatment of acanthamoeba keratitis.

Authors:  Benjamin Clarke; Arti Sinha; Dipak N Parmar; Evripidis Sykakis
Journal:  J Ophthalmol       Date:  2012-12-06       Impact factor: 1.909

Review 10.  Cross-linking for microbial keratitis.

Authors:  Jayesh Vazirani; Pravin K Vaddavalli
Journal:  Indian J Ophthalmol       Date:  2013-08       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.